SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.
Levi & Korsinsky, LLP is investigating Orexigen Therapeutics, Inc.
(NasdaqGS: OREX), and its Board of Directors, in connection with
possible claims of breaches of fiduciary duty.
To get more information, click here: http://zlk.9nl.com/orexigen-therapeutics-orex/.
There is no cost or obligation to you.
If you own common stock in Orexigen Therapeutics, Inc. and wish to
obtain additional information, please contact Eduard Korsinsky, Esq.
either via email at ek@zlk.com or by
telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/orexigen-therapeutics-orex/.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, and Washington D.C. The firm has extensive expertise in
prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and
shareholder lawsuits. The attorneys at Levi & Korsinsky have been
appointed by numerous courts throughout the country to serve as lead
counsel on behalf of shareholders in major securities lawsuits and have
successfully recovered multimillion-dollar damages awards on behalf of
investors. For more information, please feel free to contact any of the
attorneys listed below. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30
Broad Street - 24th Floor
New York, NY 10004
Tel: (212)
363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
<div class="copyright">
Copyright Business Wire 2013
</div>